Conference
900P Phase II study of individualized sunitinib (SUN) as first-line therapy for metastatic renal cell cancer: Pharmacokinetic data
Authors
Bjarnason GA; Knox J; Kollmannsberger CK; Soulieres D; Ernst DS; Zalewski P; Canil CM; Winquist E; Hotte SJ; North SA
Volume
28
Publisher
Elsevier
Publication Date
September 1, 2017
DOI
10.1093/annonc/mdx371.054
Conference proceedings
Annals of Oncology
ISSN
0923-7534